Inventor · disambiguated record
Mario Girard
Also filed as: GIRARD MARIO
16 granted patents·3 pending applications·346 citations·filing 1996–2017
93Inventor score
Top patents by PatentIndex Score
19 records- 0196US5733909ADiphenyl stilbenes as prodrugs to COX-2 inhibitorsMERCK FROSST CANADA INC·Filed 1997·Granted Mar 31, 1998·110 cites·14 claims
- 0295US5710170ATri-aryl ethane derivatives as PDE IV inhibitorsMERCK FROSST CANADA INC·Filed 1996·Granted Jan 20, 1998·108 cites·9 claims
- 0387US9290500B2Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzymeMILLENNIUM PHARM INC·Filed 2013·Granted Mar 22, 2016·10 cites·41 claims
- 0486US6743802B2Alkyne-aryl phosphodiesterase-4 inhibitorsMERCK FROSST CANADA INC·Filed 2002·Granted Jun 1, 2004·25 cites·16 claims
- 0586US6200993B1Heterosubstituted pyridine derivatives as PDE4 inhibitorsMERCK FROSST CANADA INC·Filed 2000·Granted Mar 13, 2001·30 cites·19 claims
- 0685US6180650B1Heterosubstituted pyridine derivatives as PDE 4 inhibitorsMERCK FROSST CANADA INC·Filed 2000·Granted Jan 30, 2001·30 cites·21 claims
- 0782US9751854B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2016·Granted Sep 5, 2017·3 cites·8 claims
- 0881US9802960B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Oct 31, 2017·4 cites·29 claims
- 0978US6677351B21-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitorsMERCK FROSST CANADA INC·Filed 2002·Granted Jan 13, 2004·13 cites·10 claims
- 1075US6399636B2Tri-aryl-substituted-ethane PDE4 inhibitorsMERCK FROSST CANADA INC·Filed 2001·Granted Jun 4, 2002·9 cites·17 claims
- 1173US10202373B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Feb 12, 2019·2 cites·15 claims
- 1273US8013159B2Quinoline derivatives as EP4 antagonistsMERCK CANADA INC·Filed 2006·Granted Sep 6, 2011·2 cites·17 claims
- 1361US10202389B2Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzymeMILLENNIUM PHARM INC·Filed 2017·Granted Feb 12, 2019·0 cites·7 claims
- 1461US9796725B2Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzymeMILLENNIUM PHARM INC·Filed 2017·Granted Oct 24, 2017·0 cites·15 claims
- 1552US10538533B2Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2017·Granted Jan 21, 2020·0 cites·23 claims
- 1649US6841564B2Tri-aryl-substituted-ethane PDE4 inhibitorsMERCK FROSST CANADA INC·Filed 2002·Granted Jan 11, 2005·0 cites·2 claims
- 1747US2005070569A1Alkyne-aryl phosphodiesterase-4 inhibitorsFiled 2002·Application pending·0 cites
- 1845US2006040981A1Use of phosphodiesterase-4 inhibitors as enhancers of cognitionDUBE DANIEL·Filed 2003·Application pending·0 cites
- 1944US2006167081A1Ep4 receptor agonistsBILLOT XAVIER·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mario Girard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →